OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Neutralisation Hierarchy of SARS-CoV-2 Variants of Concern Using Standardised, Quantitative Neutralisation Assays Reveals a Correlation With Disease Severity; Towards Deciphering Protective Antibody Thresholds
Diego Cantoni, Martin Mayora‐Neto, Angalee Nadesalingam, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Diego Cantoni, Martin Mayora‐Neto, Angalee Nadesalingam, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Showing 16 citing articles:
Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN study
Ana Atti, Ferdinando Insalata, Edward J Carr, et al.
Journal of Infection (2022) Vol. 85, Iss. 5, pp. 545-556
Open Access | Times Cited: 39
Ana Atti, Ferdinando Insalata, Edward J Carr, et al.
Journal of Infection (2022) Vol. 85, Iss. 5, pp. 545-556
Open Access | Times Cited: 39
Social cohesion and loneliness are associated with the antibody response to COVID-19 vaccination
Stephen Gallagher, Siobhán Howard, Orla T. Muldoon, et al.
Brain Behavior and Immunity (2022) Vol. 103, pp. 179-185
Open Access | Times Cited: 31
Stephen Gallagher, Siobhán Howard, Orla T. Muldoon, et al.
Brain Behavior and Immunity (2022) Vol. 103, pp. 179-185
Open Access | Times Cited: 31
Geographical Differences in SARS-CoV-2 Antibody Response Dynamics and Neutralisation Profiles to Mild COVID-19: Lessons from a UK–Uganda Comparison
Laban Kato, Jackson Sembera, Gerald Kevin Oluka, et al.
Vaccines (2025) Vol. 13, Iss. 4, pp. 336-336
Open Access
Laban Kato, Jackson Sembera, Gerald Kevin Oluka, et al.
Vaccines (2025) Vol. 13, Iss. 4, pp. 336-336
Open Access
Detection methods and dynamic characteristics of specific antibodies in patients with COVID-19: A review of the early literature
Jianteng Xu, Jianguo Chen, Fazhi Wen, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24580-e24580
Open Access | Times Cited: 4
Jianteng Xu, Jianguo Chen, Fazhi Wen, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24580-e24580
Open Access | Times Cited: 4
SARS-CoV-2 immunity and vaccine strategies in people with HIV
Claire Mullender, Kelly A. S. da Costa, Aljawharah Alrubayyi, et al.
Oxford Open Immunology (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 16
Claire Mullender, Kelly A. S. da Costa, Aljawharah Alrubayyi, et al.
Oxford Open Immunology (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 16
Pseudotyped Bat Coronavirus RaTG13 is efficiently neutralised by convalescent sera from SARS-CoV-2 infected patients
Diego Cantoni, Martin Mayora‐Neto, Nazia Thakur, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 15
Diego Cantoni, Martin Mayora‐Neto, Nazia Thakur, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 15
Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms
Diego Cantoni, Gabriel Siracusano, Martin Mayora‐Neto, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 58-58
Open Access | Times Cited: 12
Diego Cantoni, Gabriel Siracusano, Martin Mayora‐Neto, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 58-58
Open Access | Times Cited: 12
Spectrum Bias and Individual Strengths of SARS-CoV-2 Serological Tests—A Population-Based Evaluation
Sebastian Einhauser, David Peterhoff, Hans Helmut Niller, et al.
Diagnostics (2021) Vol. 11, Iss. 10, pp. 1843-1843
Open Access | Times Cited: 16
Sebastian Einhauser, David Peterhoff, Hans Helmut Niller, et al.
Diagnostics (2021) Vol. 11, Iss. 10, pp. 1843-1843
Open Access | Times Cited: 16
Vaccination and protective immunity to SARS-CoV-2 omicron variants in people with immunodeficiencies
Angalee Nadesalingam, Diego Cantoni, Ernest T. Aguinam, et al.
The Lancet Microbe (2022) Vol. 4, Iss. 2, pp. e58-e59
Open Access | Times Cited: 11
Angalee Nadesalingam, Diego Cantoni, Ernest T. Aguinam, et al.
The Lancet Microbe (2022) Vol. 4, Iss. 2, pp. e58-e59
Open Access | Times Cited: 11
Evolution of protective SARS-CoV-2-specific B and T cell responses upon vaccination and Omicron breakthrough infection
Mohamed I. M. Ahmed, Sebastian Einhauser, Clemens Peiter, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 110138-110138
Open Access | Times Cited: 1
Mohamed I. M. Ahmed, Sebastian Einhauser, Clemens Peiter, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 110138-110138
Open Access | Times Cited: 1
SARS-CoV-2 antibody progression and neutralizing potential in mild symptomatic COVID-19 patients – a comparative long term post-infection study
Jessica H. Brehm, Alexander Spaeth, Lars Dreßler, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 5
Jessica H. Brehm, Alexander Spaeth, Lars Dreßler, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 5
Conference Report: LPMHealthcare Emerging Viruses 2023 (EVOX23): Pandemics—Learning from the Past and Present to Prepare for the Future
Fern Jenkins, Tobias Mapulanga, Gauri Thapa, et al.
Pathogens (2024) Vol. 13, Iss. 8, pp. 679-679
Open Access
Fern Jenkins, Tobias Mapulanga, Gauri Thapa, et al.
Pathogens (2024) Vol. 13, Iss. 8, pp. 679-679
Open Access
Single ChAdOx1 nCoV‐19 dose elicits stronger immune response in previously infected individuals than in SARS‐CoV2 naive persons
Fawzi Ebrahim, Asma A Alboueishi, Inas Alhudiri, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 1
Open Access
Fawzi Ebrahim, Asma A Alboueishi, Inas Alhudiri, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 1
Open Access
Improving the Antigenicity of SARS-CoV-2 Vaccine Genes by Merging Mutations from Different Variants of Concern
Susanne Herwig, Julia M. Adler, Daria Vladimirova, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 248-248
Open Access
Susanne Herwig, Julia M. Adler, Daria Vladimirova, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 248-248
Open Access
Religious engagement and antibody response to the COVID‐19 vaccine
Grace McMahon, Renate Ysseldyk, Aoife‐Marie Foran, et al.
British Journal of Social Psychology (2024)
Open Access
Grace McMahon, Renate Ysseldyk, Aoife‐Marie Foran, et al.
British Journal of Social Psychology (2024)
Open Access
Longitudinal effects of SARS-CoV-2 breakthrough infection on imprinting of neutralizing antibody responses
Sebastian Einhauser, Claudia Asam, Manuela Weps, et al.
EBioMedicine (2024) Vol. 110, pp. 105438-105438
Closed Access
Sebastian Einhauser, Claudia Asam, Manuela Weps, et al.
EBioMedicine (2024) Vol. 110, pp. 105438-105438
Closed Access
Evolution of protective SARS-CoV-2-specific B- and T-cell responses upon vaccination and Omicron breakthrough infection
Mohamed I. M. Ahmed, Sebastian Einhauser, Clemens Peiter, et al.
Research Square (Research Square) (2023)
Open Access
Mohamed I. M. Ahmed, Sebastian Einhauser, Clemens Peiter, et al.
Research Square (Research Square) (2023)
Open Access
